Caballero, J. C., Dávila, J., López Pavía, M., Such, E., Bernal, T., Ramos, F., . . . Díez Campelo, M. (2024). Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.
Citación estilo ChicagoCaballero, Juan Carlos, et al. Outcomes and Effect of Somatic Mutations After Erythropoiesis Stimulating Agents in Patients With Lower-risk Myelodysplastic Syndromes. 2024.
Cita MLACaballero, Juan Carlos, et al. Outcomes and Effect of Somatic Mutations After Erythropoiesis Stimulating Agents in Patients With Lower-risk Myelodysplastic Syndromes. 2024.
Precaución: Estas citas no son 100% exactas.